Personalized tamoxifen dosing for breast cancer
Part of Cancer, Skin clinical trials.
This trial tests whether adjusting the dose of tamoxifen based on your body's processing can improve treatment for hormone-sensitive breast cancer. It aims to find the best dose for you while keeping side effects manageable.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with primary breast cancer and your doctor recommends tamoxifen therapy (with or without a medication to stop ovarian function).
- You are premenopausal or perimenopausal (still having periods or transitioning to menopause).
- Your daily activities are not severely limited (ECOG score 0–2).
- You agree to use non-hormonal birth control during the study.
- You have not taken tamoxifen, endoxifen, or aromatase inhibitors before.
- You do not have a history of blood clots, bleeding disorders, or certain eye conditions (like macular degeneration, retinal issues, severe cataracts, or glaucoma).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether adding alternative or complementary supports can improve how well people stick with tamoxifen treatment for early hormone-related breast cancer. If it helps adherence, it may help people benefit more reliably from their prescribed therapy.
This trial compares two low-dose medications, exemestane and tamoxifen, to see which is better at preventing breast cancer in postmenopausal women who have a higher risk. You would take one of these pills daily for a few years, and the study will check how well it works and what side effects occur.
This trial studies treatments given before surgery for invasive breast cancer, aiming to shrink the tumor so surgery can be done more effectively. It may help some people need breast-conserving surgery or improve the chance of complete cancer removal.
This trial is testing two low-dose hormone therapies (exemestane and tamoxifen) to see which works better for preventing breast cancer in postmenopausal women who are at high risk. It's a double-blind study, so neither you nor your doctor will know which drug you're taking.
This trial tests if giving hormone-blocking pills before surgery can help guide which treatments you need after surgery. It is for premenopausal women with early-stage, hormone-sensitive breast cancer.
This trial tests whether switching to a different aromatase inhibitor or using standard treatments works better for managing side effects in breast cancer survivors. It aims to help you stay on hormone therapy longer with fewer discomforts.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.